Research Article
Shenmayizhi Formula Combined with Ginkgo Extract Tablets for the Treatment of Vascular Dementia: A Randomized, Double-Blind, Controlled Trial
Table 5
Comparison of NSE, BDNF, and Hcy in the 2 groups before and after treatment.
| | SMYZF group (n = 85), median (IQR) | Ginkgo group (n = 87), median (IQR) | value |
| NSE | | | | Before treatment | 7.42 (5.97–10.06) | 7.75 (6.14–9.96) | 0.877 | After treatment | 5.20 (4.23–6.08) | 5.93 (4.65–7.55) | 0.030 | BDNF | | | | Before treatment | 22.88 (14.79–32.70) | 26.02 (17.52–32.86) | 0.389 | After treatment | 38.79 (34.59–45.06) | 35.78 (29.72–44.29) | 0.026 | Hcy | | | | Before treatment | 8.87 (6.08–14.63) | 9.62 (6.36–15.01) | 0.595 | After treatment | 6.58 (4.83–9.95) | 6.76 (3.89–12.5) | 0.995 |
|
|
Significant effect ( < 0.05). |